Latest Featured Stories
Many patients with treatment-resistant blood cancers have found new hope in chimeric antigen receptor (CAR)-T cell therapy. But generation of CAR-T cells at clinical scale can be challenging. Find out how the Gene Pulser Xcell Electroporation System can be used to reduce costs and risks associated with clinical-scale CAR-T cell production, while maintaining GMP compliance.
Many BioPharma organizations are moving to the cloud in order to improve the performance and speed, cost, physical and personnel resources, security, back up, and sharing/collaboration associated with large, complex datasets. Learn about the different strategies used in migrating to the cloud.